Patient presents with signs and symptoms consistent with onychomycosis, commonly known as toe fungus or toenail fungus.  The affected nail(s) exhibit clinical manifestations such as thickening, discoloration (yellow, brown, or white), brittleness, crumbling, distortion, and possible separation from the nail bed (onycholysis).  The patient reports [Insert patient-reported symptoms, e.g., pain, discomfort, foul odor, difficulty trimming nails].  Differential diagnosis includes psoriasis, lichen planus, and trauma.  Based on the clinical presentation and patient history, the diagnosis of distal subungual onychomycosis is suspected.  Treatment options discussed with the patient include topical antifungal medications (e.g., ciclopirox, efinaconazole, tavaborole), oral antifungal medications (e.g., terbinafine, itraconazole),  laser therapy, and debridement.  Risks and benefits of each treatment option were explained, including potential side effects, duration of therapy, and efficacy rates.  The patient opted for [Insert chosen treatment].  Patient education provided regarding proper foot hygiene, including keeping feet clean and dry, wearing breathable footwear, and avoiding sharing personal care items.  Follow-up appointment scheduled in [ timeframe ] to monitor treatment progress and assess for improvement in nail appearance and resolution of symptoms.  ICD-10 code B35.1 will be used for billing purposes.  CPT codes for treatment will be determined based on the specific procedures performed.